List of Patents

We are actively seeking opportunities for in-licensing of complementary technologies and out-licensing of Sengenics biomarker patents. Please contact us to arrange a discussion.

KREX™, IMMUNOME™,  SYMPHONI™ and OncoREX™ are registered trademarks of Sengenics and is protected by one or more of the following Patents:


1 JP4377242 Methods of determining method, and a folded state to increase the protein tag, and solubility including biotinylation domain View Patent
2 AU2002352355 Protein arrays for allelic variants and uses thereof View Patent
3 CA2469403 Protein arrays for allelic variants and uses thereof View Patent
4 EP1456668 Protein arrays for allelic variants and uses thereof View Patent
5 AU2003238441 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state View Patent
6 CA2474457 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state View Patent
7 EP1470229 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state View Patent
8 GB2361698 Modification of DNA molecules View Patent
9 EP1485411 Arrays of cytosolic accessory proteins immobilized on a surface and pertinent methods View Patent
10 US8999897 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state View Patent
11 JP4730804 Generating protein arrays View Patent
12 JP4781628 Protein arrays and their use for the allelic variants View Patent
13 US7816098 Methods of making and using a protein array View Patent
14 US20180305840 Protein arrays and their use to assay the protein products of highly homologous or related DNA coding sequences View Patent


1 US20180321244A1 Method for detection and diagnosis of Oral Cancer in a sample View Patent
2 AU2018100578A4 Method for detection and diagnosis of Oral Cancer in a sample View Patent
3 10201811119X Detection of biomarkers for Non-Small Cell Lung Cancer N/A
4 10201908922U Identification of health status in the elderly using immunological biomarkers N/A


1 N/A Biomarkers for predicting immunogenicity and therapeutic responses to adalimumab in rheumatoid arthritis patients N/A

FEATURED PRODUCTS

IMMUNOME Protein Array

High-throughput multiplexed autoantibody screening protein array containing 1600+
autoantigens

ImmuSAFE COVID Tests

Contains correctly folded antigens from SARS-CoV-2 and 25 other Corona and Influenza
viruses

SARS-CoV-2 Antigens

7 Recombinant SARS-CoV-2 antigens expressed using the patented KREX™ functional proteomics technology

Sengenics - Functional Proteomics | Krex Technology | Protein Array Supplier

Sengenics is a functional proteomics company that leverages its patented KREX technology for production of full-length, correctly folded and functional proteins. The key application of KREX is the discovery of autoantibody biomarkers for two core medical use cases:  stratification of patients undergoing treatment with autoimmune or cancer drugs and identification of autoantibody biomarkers that may be used to diagnose cancer, autoimmune or neurodegenerative conditions. Some autoantibodies that are identified as diagnostic biomarkers may be protective and have potential in themselves as therapeutic biomolecules.

Find Us On:

2008 – 2020© Sengenics All rights reserved | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D | Sengenics UK Ltd. Registered in England and Wales No 11016361 

X